fbpx

What is a Dendritic Cell and How Does it Contribute to the Immune System?

Dendritic cells (DCs) are pivotal antigen-presenting cells in the immune system. Their role encompasses the initiation and modulation of immune responses, acting as a bridge between innate and adaptive immunity. This essay explores the characteristics, functions, and clinical relevance of dendritic cells, highlighting their contribution to immunological responses and potential therapeutic applications.

The immune system is an intricate network of cells and molecules designed to protect the body from pathogens. Among these immune cells, dendritic cells are especially critical due to their ability to initiate and regulate immune responses. First described by Paul Langerhans in the late 19th century, the true immunological function of dendritic cells was elucidated decades later by Ralph Steinman, for which he received the Nobel Prize in Physiology or Medicine in 2011 (Steinman, 2011).

Dendritic cells are characterized by their distinct morphology, marked by membrane projections resembling dendrites in neurons, which maximize contact with their surroundings (Banchereau & Steinman, 1998). They originate from bone marrow precursors and are distributed throughout peripheral tissues and the lymphatic system. DCs are broadly categorized into two main types: myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs), each with unique receptors and functions (Collin et al., 2013).

In innate immunity, dendritic cells act as first responders to pathogenic threats. They are equipped with pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), which detect pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) (Kawai & Akira, 2010). Upon activation, dendritic cells undergo maturation, characterized by increased expression of co-stimulatory molecules and cytokine production, crucial for initiating an immune response.

Dendritic cells are essential in linking innate and adaptive immunity. Their primary role is to process and present antigens to T cells. Upon encountering an antigen, dendritic cells phagocytize the pathogen, process its antigens, and present them on their surface via major histocompatibility complex (MHC) molecules. This antigen presentation is critical for the activation of T cells, which are central to the adaptive immune response (Banchereau & Steinman, 1998).

DCs present antigens to T cells in the lymph nodes, a process that requires their migration from peripheral tissues via the lymphatic system. The interaction between DCs and T cells involves not only antigen presentation but also the engagement of co-stimulatory molecules and the secretion of cytokines, which determine the type of immune response (e.g., Th1, Th2) that will be developed (Cella et al., 1997).

Dendritic cells are not only initiators but also regulators of immune responses. They have the ability to induce tolerance, an essential mechanism to prevent autoimmune diseases. This is achieved by promoting regulatory T cell (Treg) responses through the expression of inhibitory molecules and the secretion of anti-inflammatory cytokines (Steinman et al., 2003).

The unique properties of dendritic cells have been harnessed in various therapeutic strategies, particularly in cancer immunotherapy. Dendritic cell-based vaccines, where DCs are loaded with tumor antigens and reinfused into the patient, aim to elicit a robust antitumor T cell response (Palucka & Banchereau, 2012). Additionally, modulation of dendritic cell function is being explored in the management of autoimmune disorders and transplant rejection.

Dendritic cells are indispensable to the immune system, providing critical links between innate and adaptive immunity. Their ability to process and present antigens makes them pivotal in the defense against pathogens and in the maintenance of immune homeostasis. Further understanding of dendritic cell biology may unlock new therapeutic potentials for treating a variety of diseases.

References:

Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392(6673), 245-252.

Cella, M., Sallusto, F., & Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology, 9(1), 10-16.

Collin, M., McGovern, N., & Haniffa, M. (2013). Human dendritic cell subsets. Immunology, 140(1), 22-30.

Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology, 11(5), 373-384.

Palucka, K., & Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nature Reviews Cancer, 12(4), 265-277.

Steinman, R. M. (2011). Dendritic cells in vivo: a key target for a new vaccine science. Immunity, 35(2), 223-227.

Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annual Review of Immunology, 21, 685-711.

If you have any questions about the Berkeley Formula Diindolylmethane (DIM) Supplement & Immune System Booster, please feel free to contact our customer service department at 877-777-0719 (9AM-5PM M-F PST) and our representatives will be happy to answer any questions that you may have. We will be glad to share with you why the Berkeley Formula is the DIM supplement of choice by nutritional scientists, medical professionals and biomedical investigators worldwide.

Romanesco Broccoli with a Natural Fractal Pattern

Romanesco Broccoli

What is a Dendritic Cell and How Does it Contribute to the Immune System?

Dendritic cells (DCs) are pivotal antigen-presenting cells in the immune system. Their role encompasses the initiation and modulation of immune responses, acting as a bridge between innate and adaptive immunity. This essay explores the characteristics, functions, and clinical relevance of dendritic cells, highlighting their contribution to immunological responses and potential therapeutic applications.

The immune system is an intricate network of cells and molecules designed to protect the body from pathogens. Among these immune cells, dendritic cells are especially critical due to their ability to initiate and regulate immune responses. First described by Paul Langerhans in the late 19th century, the true immunological function of dendritic cells was elucidated decades later by Ralph Steinman, for which he received the Nobel Prize in Physiology or Medicine in 2011 (Steinman, 2011).

Dendritic cells are characterized by their distinct morphology, marked by membrane projections resembling dendrites in neurons, which maximize contact with their surroundings (Banchereau & Steinman, 1998). They originate from bone marrow precursors and are distributed throughout peripheral tissues and the lymphatic system. DCs are broadly categorized into two main types: myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs), each with unique receptors and functions (Collin et al., 2013).

In innate immunity, dendritic cells act as first responders to pathogenic threats. They are equipped with pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), which detect pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) (Kawai & Akira, 2010). Upon activation, dendritic cells undergo maturation, characterized by increased expression of co-stimulatory molecules and cytokine production, crucial for initiating an immune response.

Dendritic cells are essential in linking innate and adaptive immunity. Their primary role is to process and present antigens to T cells. Upon encountering an antigen, dendritic cells phagocytize the pathogen, process its antigens, and present them on their surface via major histocompatibility complex (MHC) molecules. This antigen presentation is critical for the activation of T cells, which are central to the adaptive immune response (Banchereau & Steinman, 1998).

DCs present antigens to T cells in the lymph nodes, a process that requires their migration from peripheral tissues via the lymphatic system. The interaction between DCs and T cells involves not only antigen presentation but also the engagement of co-stimulatory molecules and the secretion of cytokines, which determine the type of immune response (e.g., Th1, Th2) that will be developed (Cella et al., 1997).

Dendritic cells are not only initiators but also regulators of immune responses. They have the ability to induce tolerance, an essential mechanism to prevent autoimmune diseases. This is achieved by promoting regulatory T cell (Treg) responses through the expression of inhibitory molecules and the secretion of anti-inflammatory cytokines (Steinman et al., 2003).

The unique properties of dendritic cells have been harnessed in various therapeutic strategies, particularly in cancer immunotherapy. Dendritic cell-based vaccines, where DCs are loaded with tumor antigens and reinfused into the patient, aim to elicit a robust antitumor T cell response (Palucka & Banchereau, 2012). Additionally, modulation of dendritic cell function is being explored in the management of autoimmune disorders and transplant rejection.

Dendritic cells are indispensable to the immune system, providing critical links between innate and adaptive immunity. Their ability to process and present antigens makes them pivotal in the defense against pathogens and in the maintenance of immune homeostasis. Further understanding of dendritic cell biology may unlock new therapeutic potentials for treating a variety of diseases.

References:

Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392(6673), 245-252.

Cella, M., Sallusto, F., & Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology, 9(1), 10-16.

Collin, M., McGovern, N., & Haniffa, M. (2013). Human dendritic cell subsets. Immunology, 140(1), 22-30.

Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology, 11(5), 373-384.

Palucka, K., & Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nature Reviews Cancer, 12(4), 265-277.

Steinman, R. M. (2011). Dendritic cells in vivo: a key target for a new vaccine science. Immunity, 35(2), 223-227.

Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annual Review of Immunology, 21, 685-711.

If you have any questions about the Berkeley Formula Diindolylmethane (DIM) Supplement & Immune System Booster, please feel free to contact our customer service department at 877-777-0719 (9AM-5PM M-F PST) and our representatives will be happy to answer any questions that you may have. We will be glad to share with you why the Berkeley Formula is the DIM supplement of choice by nutritional scientists, medical professionals and biomedical investigators worldwide.

Romanesco Broccoli with a Natural Fractal Pattern

Romanesco Broccoli
Berkeley Immune Support Formula Immune Booster Supplement
Alex Amini, M.D. Quote

Alex Amini, M.D.
Infectious Disease Specialist
Kaiser Permanente

Broccoli
Broccoli:
Diindolylmethane
Sulforaphane
Selenium
Spinach
Spinach:
Lutein
Zeaxanthin
Citrus Fruits
Citrus Fruits:
Citrus Bioflavonoids
Tomato
Tomato:
Lycopene
Broccoli
Broccoli:
Diindolylmethane
Sulforaphane
Selenium
  • Powerful Nutritional Immune Booster

    Bioavailable Nutrient Delivery System

  • Diindolylmethane (DIM):

    Immune, Breast, Prostate & Colon Heath

  • Sulforaphane:

    Cellular Detoxification

  • Selenium:

    Immune, Breast, Prostate & Vision Health

  • Lycopene:

    Cardiovascular, Breast & Prostate Health

  • Lutein:

    Immune, Vision, Prostate & Skin Health

  • Zeaxanthin:

    Vision Health

  • Vitamin D3:

    Immune Support & Bone Health

  • Citrus Bioflavonoids:

    Immune & Cardiovascular Health

  • Zinc:

    Immune, Breast, Prostate & Vision Health

Berkeley Immune Support Formula supplement facts sheet
Berkeley Immune Support Formula Capsule

Premium Immune Booster